Earnings
ConMed Cuts Top Of Growth Outlook To 5.5%, Says Distributor Order Timing Flattered Third Quarter
The CFO says it beat the low end of its third-quarter revenue guidance by $1.5 million and did not carry that into the fourth quarter.
CNMD
CONMED (CNMD) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Earnings
ConMed CEO Won't Discuss Strategic Action Rumor — But Says He Can See Why 'Somebody Would Be Attracted'
CEO Pat Beyer cited 6.7% organic constant currency growth and a sharper three-market focus after a JPMorgan analyst asked about strategic action.
SEC Filings
CONMED Keeps Buying Back Stock With $180 Million Drawn On Its Revolver And Convertible Notes Due In June 2027
The surgical-device maker has used $49.9 million of a $150.0 million buyback and says cash flow and its credit line will cover the 2027 note maturity.
Earnings
CONMED Narrows Its 2026 Sales Range, Raises Profit Forecast As Margin Widens To 56.4%
The surgical-device maker's third-quarter sales slipped 0.7% as it exited GI products, while gross margin climbed from 49.2% a year earlier.